BRIEF published on 03/13/2025 at 13:50, 11 months 28 days ago Bonyf Secures EU Patent for PerioTabs® & PerioCream, US Patent Pending Global Launch Oral Healthcare Dental Innovation IDS 2025 Patent Secured
BRIEF published on 03/13/2025 at 13:50, 11 months 28 days ago Bonyf obtient un brevet européen pour PerioTabs® et PerioCream, brevet américain en attente Lancement Mondial Soins Bucco-dentaires Innovation Dentaire IDS 2025 Brevet Obtenu
BRIEF published on 03/13/2025 at 13:46, 11 months 28 days ago Apex Fundrock's Disclosure on Equals Group PLC Form 8.3 Takeover Code Securities Disclosure Chelverton Asset Management Equals Group
BRIEF published on 03/13/2025 at 13:46, 11 months 28 days ago Divulgation d'Apex Fundrock concernant Equals Group PLC Code De Prise De Contrôle Formulaire 8.3 Gestion D'actifs Chelverton Divulgation Des Valeurs Mobilières Groupe Equals
BRIEF published on 03/13/2025 at 13:43, 11 months 28 days ago Reply S.p.A. Reports Strong Financial Results for 2024 Financial Results Sustainability Artificial Intelligence Dividend Proposal Turnover Growth
BRIEF published on 03/13/2025 at 13:43, 11 months 28 days ago Reply SpA annonce de solides résultats financiers pour 2024 Résultats Financiers Durabilité Intelligence Artificielle Croissance Du Chiffre D'affaires Proposition De Dividende
BRIEF published on 03/13/2025 at 13:35, 11 months 28 days ago Xenetic Biosciences Reveals Promising Preclinical Data for DNase I in Cancer Therapy Xenetic Biosciences Cancer Treatment Preclinical Data DNase I Therapy CAR T Cells
BRIEF published on 03/13/2025 at 13:35, 11 months 28 days ago Xenetic Biosciences révèle des données précliniques prometteuses sur l'ADNase I dans le traitement du cancer Traitement Du Cancer Biosciences Xénétiques Données Précliniques Cellules CAR-T Thérapie À La DNase I
BRIEF published on 03/13/2025 at 13:35, 11 months 28 days ago Aspire Biopharma Updates on U.S. Patent Filings for Drug Delivery Platform Clinical Trials Patent Applications Sublingual Delivery Rapid Absorption Aspirin Formulation
BRIEF published on 03/13/2025 at 13:35, 11 months 28 days ago Aspire Biopharma fait le point sur les dépôts de brevets américains pour sa plateforme d'administration de médicaments Essais Cliniques Demandes De Brevet Administration Sublinguale Absorption Rapide Formulation D'aspirine
Published on 03/10/2026 at 22:30, 13 minutes ago Ur-Energy Reports Year-End 2025 Results and Announces Conference Call and Webcast
Published on 03/10/2026 at 22:15, 28 minutes ago Avino Reports Exceptional 2025 Results and Advances Multi-Asset Growth Strategy; Significant Improvements Across Key Financial Metrics; Treasury Reaches Record Levels
Published on 03/10/2026 at 21:30, 1 hour 13 minutes ago Mako Mining Files Technical Report for Moss Mine Mineral Resource Estimate
Published on 03/10/2026 at 21:01, 1 hour 42 minutes ago Evergold Announces Non-Brokered Private Placement of up to $5,000,000 for Drilling at Golden Lion, Toodoggone Region, Northern BC
Published on 03/10/2026 at 21:33, 1 hour 10 minutes ago EQS-Adhoc: Gerresheimer AG: Publication of the 2025 annual and consolidated financial statements only after March 31, 2026, exclusion from the SDAX, postponement of the Annual General Meeting
Published on 03/10/2026 at 19:40, 3 hours 3 minutes ago EQS-Adhoc: Deutsche Rohstoff AG: Preliminary figures for 2025: Revenue above forecast, EBITDA at the upper end of guidance range
Published on 03/10/2026 at 18:57, 3 hours 46 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 03/10/2026 at 18:38, 4 hours 5 minutes ago EQS-Adhoc: NAKIKI SE: Request to convene an extraordinary general meeting
Published on 03/10/2026 at 17:45, 4 hours 58 minutes ago Number of outstanding shares and voting rights as of 28 February 2026
Published on 03/10/2026 at 17:45, 4 hours 58 minutes ago Nombre de droits de vote et d'actions composant le capital social au 28 février 2026
Published on 03/10/2026 at 17:45, 4 hours 58 minutes ago OPmobility reshapes its Executive Committee to further adapt to market needs and accelerate the execution of its strategy
